As per annexure enclosed
Awaiting price reaction for this filing.
Apollo Hospitals reported its audited standalone and consolidated financial results for Q4 and FY ended March 31, 2025. Consolidated revenue from operations grew to Rs.21,794 crore (FY25) from Rs.19,059 crore (FY24), while consolidated profit after tax jumped to Rs.1,505 crore from Rs.935 crore, a rise of about 61%. Standalone revenue grew to Rs.8,202 crore from Rs.7,274 crore with standalone PAT at Rs.1,296 crore (up ~28%). The Board recommended a final dividend of Rs.10 per share, taking the total FY25 dividend to Rs.19 per share (380%), aggregating Rs.273.2 crore. The Board also approved re-appointment of the three Reddy sisters as Executive Directors and Mr. Som Mittal as Independent Director, and appointed M/s. Lakshmmi Subramanian & Associates as Secretarial Auditors for five years. A Rs.285 crore acquisition of an existing 200-bed hospital was also approved.
Strong earnings growth, especially on the consolidated side, and a healthy total dividend of Rs.19/share are positives for shareholders. The hospital acquisition signals continued capacity expansion. Credit ratings were reaffirmed at AA+ with stable outlook, reflecting financial stability.